Locations:
Search IconSearch
March 22, 2024/Cancer/Innovations

The Vital Role of Oncology Rehabilitation (Podcast)

New program provides prehabilitation and rehabilitation services to help patients with cancer maintain and regain function

Cleveland Clinic physiatrist

Oncology patients often face conditions that impact their function, ranging from neuropathic pain to lymphedema. A newly launched oncology rehabilitation program at Cleveland Clinic aims to help patients maintain and regain function during their diagnosis, treatment and recovery.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

“We treat the person, not the disease,” says Eileen Slavin, DO, a physiatrist specializing in oncology rehabilitation who leads the program. “So, we have to think about every person’s unique characteristics, unique challenges, specific requests – depending on their hobbies, their activities – and what they are facing.”

In a recent episode of Cleveland Clinic’s Cancer Advances podcast, Dr. Slavin talks about the role of oncology prehabilitation and rehabilitation. She discusses:

  • The array of cancer diagnoses and disease side effects the program addresses
  • Patient selection factors and who benefits from prehabilitation and rehabilitation
  • Multidisciplinary teamwork between physiatrists, oncologists, physical and occupational therapists, dietitians and others
  • Research into the survival benefit of oncology rehabilitation
  • The evolution of immunotherapy and what that means for treating its side effects

Click the podcast player above to listen to the episode now, or read on for a short edited excerpt. Check out more Cancer Advances episodes at clevelandclinic.org/podcasts/cancer-advances or wherever you get your podcasts.

Excerpt from the podcast:

Podcast host Dale Shepard, MD, PhD: If we think about patient selection, who are the optimal people to have you see? What kind of patient selection factors do you think about?

Eileen Slavin, DO: Patients who have certain risk factors in comorbidities. So, someone who might have an elevated BMI, someone who might have chronic pain syndromes, a patient who has a diagnosis of diabetes who might have difficulty with healing. Patients who are certainly motivated and interested in doing prehab, of course, are good candidates.

Advertisement

Patient selection can be sort of tricky, but thinking about that patient that you might worry would slip through the cracks. And maybe that patient is already having a little bit of difficulty with their diagnosis, is already asking questions like, “Well, will I be able to get up and walk around? Will I have this type of pain? Will I lose function?” Those are also patients who would be good to refer to our service.

Advertisement

Related Articles

Dr. Abhay Singh
May 14, 2025/Cancer
Managing Weight and Diabetes May Offer Promise for Blood Cancer Prevention (Podcast)

Use of GLP-1s and improving cardiovascular health lowers risk of hematologic malignancies

Pediatrician with child
Setting Standards in the Delivery of Pediatric Cancer Care

Leaders of the Pediatric Cancer Committee discuss new accreditation

Seth Rotz, MD, exams patient's throat during clinical exam
Study Reveals New Clues Into Childhood Cancer Survivors’ Increased Risk of Melanoma

Largest study of its kind identifies three treatment exposures that contribute to risk

Silhouettes of man and woman
February 7, 2025/Cancer/News & Insight
Pharmacokinetics of Many Anticancer Drugs Differ Among Sexes

Slower drug elimination from the body among females may impact safety and efficacy

Young patient with cancer
October 25, 2024/Cancer/News & Insight
Multidisciplinary Care Model Supports Young People with Cancer

Integrated program addresses growing need for comprehensive cancer care among adolescents, young adults and adults under 50 with early onset cancers

Genetic sequencing
September 26, 2024/Cancer
AI Can Help Find Trials for Patients with Rare Cancers

Study demonstrates potential for improving access

Dr. Holly Pederson
July 25, 2024/Cancer/Research
Evaluating Risk Scores for Triple-Negative Breast Cancer in Black Women (Podcast)

Polygenic risk score could help predict who will develop this aggressive breast cancer

Image showing Dr. Gupta
June 20, 2024/Cancer/Research
Trailblazing Urothelial Cancer Treatments (Podcast)

Platinum-eligible phase 3 trial of enfortumab vedotin and pembrolizumab yields ‘unprecedented data’

Ad